These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24766977)

  • 1. Galectin-3 is independently associated with cardiovascular mortality in community-dwelling older adults without known cardiovascular disease: The Rancho Bernardo Study.
    Daniels LB; Clopton P; Laughlin GA; Maisel AS; Barrett-Connor E
    Am Heart J; 2014 May; 167(5):674-82.e1. PubMed ID: 24766977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study.
    Daniels LB; Barrett-Connor E; Clopton P; Laughlin GA; Ix JH; Maisel AS
    J Am Coll Cardiol; 2012 Mar; 59(12):1101-9. PubMed ID: 22421304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study.
    Daniels LB; Clopton P; Laughlin GA; Maisel AS; Barrett-Connor E
    Circulation; 2011 May; 123(19):2101-10. PubMed ID: 21536998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.
    Daniels LB; Laughlin GA; Clopton P; Maisel AS; Barrett-Connor E
    J Am Coll Cardiol; 2008 Aug; 52(6):450-9. PubMed ID: 18672166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of galectin-3 on admission in Chinese patients with heart failure: a prospective observational study.
    Wang H; Chen Q; Li Y; Jing X; Liang T; Yang J
    Acta Cardiol; 2017 Apr; 72(2):188-195. PubMed ID: 28597803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fibrosis marker galectin-3 and outcome in the general population.
    de Boer RA; van Veldhuisen DJ; Gansevoort RT; Muller Kobold AC; van Gilst WH; Hillege HL; Bakker SJ; van der Harst P
    J Intern Med; 2012 Jul; 272(1):55-64. PubMed ID: 22026577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
    Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
    Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3 is an independent predictor of survival in systemic sclerosis.
    Faludi R; Nagy G; Tőkés-Füzesi M; Kovács K; Czirják L; Komócsi A
    Int J Cardiol; 2017 Apr; 233():118-124. PubMed ID: 28043664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-Analysis of the Usefulness of Plasma Galectin-3 to Predict the Risk of Mortality in Patients With Heart Failure and in the General Population.
    Imran TF; Shin HJ; Mathenge N; Wang F; Kim B; Joseph J; Gaziano JM; Djoussé L
    Am J Cardiol; 2017 Jan; 119(1):57-64. PubMed ID: 28247849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of lung function with coronary heart disease and cardiovascular disease outcomes in elderly: the Rancho Bernardo study.
    Lee HM; Liu MA; Barrett-Connor E; Wong ND
    Respir Med; 2014 Dec; 108(12):1779-85. PubMed ID: 25448311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma-free fatty acids, fatty acid-binding protein 4, and mortality in older adults (from the Cardiovascular Health Study).
    Miedema MD; Maziarz M; Biggs ML; Zieman SJ; Kizer JR; Ix JH; Mozaffarian D; Tracy RP; Psaty BM; Siscovick DS; Mukamal KJ; Djousse L
    Am J Cardiol; 2014 Sep; 114(6):843-8. PubMed ID: 25073566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3 and risk of cardiovascular events and all-cause mortality in type 2 diabetes.
    Tan KCB; Cheung CL; Lee ACH; Lam JKY; Wong Y; Shiu SWM
    Diabetes Metab Res Rev; 2019 Feb; 35(2):e3093. PubMed ID: 30378236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pericardial fat is associated with all-cause mortality but not incident CVD: the Rancho Bernardo Study.
    Larsen BA; Laughlin GA; Saad SD; Barrett-Connor E; Allison MA; Wassel CL
    Atherosclerosis; 2015 Apr; 239(2):470-5. PubMed ID: 25702617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different impacts of hypertension and diabetes mellitus on all-cause and cardiovascular mortality in community-dwelling older adults: the Rancho Bernardo Study.
    Oh JY; Allison MA; Barrett-Connor E
    J Hypertens; 2017 Jan; 35(1):55-62. PubMed ID: 27906837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels and Change in Galectin-3 and Association With Cardiovascular Events: The ARIC Study.
    Aguilar D; Sun C; Hoogeveen RC; Nambi V; Selvin E; Matsushita K; Saeed A; McEvoy JW; Shah AM; Solomon SD; Boerwinkle E; Ballantyne CM
    J Am Heart Assoc; 2020 Jul; 9(13):e015405. PubMed ID: 32573308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of galectin-3 for predicting cause-specific death in hospitalized patients with heart failure.
    Zhang Y; Zhang R; An T; Huang Y; Guo X; Yin S; Wang Y; Ji S; Lv R; Zhang J; Maisel A
    J Card Fail; 2015 Jan; 21(1):51-9. PubMed ID: 25463412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes.
    Ghorbani A; Bhambhani V; Christenson RH; Meijers WC; de Boer RA; Levy D; Larson MG; Ho JE
    J Am Coll Cardiol; 2018 Dec; 72(25):3246-3254. PubMed ID: 30573026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study.
    van Peet PG; de Craen AJ; Gussekloo J; de Ruijter W
    Age (Dordr); 2014 Jun; 36(3):9660. PubMed ID: 24807464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Serial Galectin-3 Measurements in Patients With Acute Heart Failure.
    van Vark LC; Lesman-Leegte I; Baart SJ; Postmus D; Pinto YM; de Boer RA; Asselbergs FW; Wajon EMCJ; Orsel JG; Boersma E; Hillege HL; Akkerhuis KM;
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.